: 1 BPC-157, Revange Nutrition, 60 caps Revange : 5 830
Retatrutide 30mg is a lyophilized triple receptor agonist research peptide listed under the Novera Compounds brand in the United States, supplied in a 30mg vial requiring reconstitution with BAC water (bacteriostatic water) prior to laboratory use

Some notable safety-related conclusions from scientific materials include: A 2016 review of TB4 for dermal healing: The safety profile is excellent, and no preclinical toxicology has been found.22 A 2016 clinical trial on patients with STEMI: Our pilot study suggested that T4-optimized EPC transplantation appeared to be feasible and safe.34 A 2021 review of TB4 research: It was well tolerated and safe in healthy people and suitable for use in a clinical study.21 Though the compound itself may be generally safe for adults to use, some common side effects from TB4 injections reported by patients and doctors include: Injection site reactions (e.g., redness, mild swelling, or pain) Mild gastrointestinal symptoms Headaches and dizziness Rare but more serious side effects can include fever, blistering at the injection site, muscle aches, skin rash, vomiting, severe itching, or hives
This article walks through the comparison so longevity researchers can match the format to their research
PubMed PMID: 10469335
What are the side effects of using peptides